Weihua Wang
Zhejiang Province Key Laboratory Of Anti Cancer Drug Research
Hangzhou, 310058, China
Hangzhou, 310058, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
USP10-mediated deubiquitination and activation of KRAS mutants promotes colorectal cancer via a novel USP10/KRAS positive feedback circuit.
Journal: Acta pharmaceutica Sinica. B
Published: February 22, 2025
Glutamine Production by Glul Promotes Thermogenic Adipocyte Differentiation Through Prdm9-Mediated H3K4me3 and Transcriptional Reprogramming.
Journal: Diabetes
Published: February 26, 2023
Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.
Journal: Signal transduction and targeted therapy
Published: January 05, 2023
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer.
Journal: Frontiers in pharmacology
Published: January 02, 2023
Discovery of Novel Indazoles as Potent and Selective PI3Kδ Inhibitors with High Efficacy for Treatment of Hepatocellular Carcinoma.
Journal: Journal of medicinal chemistry
Published: February 22, 2022
Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression.
Journal: Acta pharmaceutica Sinica. B
Published: December 21, 2020
The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
Journal: Theranostics
Published: August 08, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026